Free Trial

Janus Henderson Group PLC Makes New $737,000 Investment in Bowhead Specialty Holdings Inc. (NYSE:BOW)

Bowhead Specialty logo with Finance background

Janus Henderson Group PLC purchased a new position in Bowhead Specialty Holdings Inc. (NYSE:BOW - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 20,751 shares of the company's stock, valued at approximately $737,000. Janus Henderson Group PLC owned approximately 0.06% of Bowhead Specialty as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently modified their holdings of the company. The Manufacturers Life Insurance Company lifted its holdings in shares of Bowhead Specialty by 0.8% in the fourth quarter. The Manufacturers Life Insurance Company now owns 60,963 shares of the company's stock valued at $2,165,000 after buying an additional 455 shares during the period. Summit Investment Advisors Inc. raised its position in Bowhead Specialty by 66.4% in the fourth quarter. Summit Investment Advisors Inc. now owns 1,218 shares of the company's stock worth $43,000 after acquiring an additional 486 shares in the last quarter. Sei Investments Co. boosted its position in shares of Bowhead Specialty by 0.8% during the 4th quarter. Sei Investments Co. now owns 94,395 shares of the company's stock valued at $3,353,000 after purchasing an additional 760 shares in the last quarter. Schroder Investment Management Group grew its stake in shares of Bowhead Specialty by 0.3% in the 4th quarter. Schroder Investment Management Group now owns 365,886 shares of the company's stock worth $12,641,000 after purchasing an additional 1,209 shares during the last quarter. Finally, New York State Common Retirement Fund acquired a new position in shares of Bowhead Specialty in the 4th quarter worth approximately $64,000.

Analysts Set New Price Targets

A number of analysts recently weighed in on BOW shares. Morgan Stanley raised their target price on shares of Bowhead Specialty from $36.00 to $39.00 and gave the stock an "equal weight" rating in a report on Monday, May 19th. Keefe, Bruyette & Woods lifted their target price on Bowhead Specialty from $43.00 to $45.00 and gave the stock an "outperform" rating in a report on Friday, May 9th. JMP Securities boosted their target price on Bowhead Specialty from $38.00 to $40.00 and gave the stock a "market outperform" rating in a research report on Friday, April 11th. Piper Sandler started coverage on Bowhead Specialty in a report on Wednesday, April 16th. They set an "overweight" rating and a $44.00 target price for the company. Finally, JPMorgan Chase & Co. lifted their price target on Bowhead Specialty from $30.00 to $35.00 and gave the stock a "neutral" rating in a research note on Tuesday, April 8th. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $39.67.

Read Our Latest Research Report on BOW

Insider Transactions at Bowhead Specialty

In related news, Director Ava Schnidman acquired 1,493 shares of the stock in a transaction that occurred on Friday, February 28th. The shares were purchased at an average cost of $33.41 per share, with a total value of $49,881.13. Following the completion of the transaction, the director now owns 1,893 shares of the company's stock, valued at approximately $63,245.13. This trade represents a 373.25% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this link.

Bowhead Specialty Stock Up 1.8%

Shares of Bowhead Specialty stock traded up $0.67 during midday trading on Thursday, hitting $37.17. The company's stock had a trading volume of 165,821 shares, compared to its average volume of 199,923. Bowhead Specialty Holdings Inc. has a 1-year low of $23.70 and a 1-year high of $42.29. The firm has a market capitalization of $1.21 billion and a P/E ratio of 28.37. The stock has a 50-day simple moving average of $39.30 and a 200-day simple moving average of $35.93.

Bowhead Specialty (NYSE:BOW - Get Free Report) last announced its quarterly earnings data on Tuesday, May 6th. The company reported $0.34 EPS for the quarter, topping analysts' consensus estimates of $0.33 by $0.01. The business had revenue of $174.85 million for the quarter, compared to analyst estimates of $105.17 million. As a group, sell-side analysts predict that Bowhead Specialty Holdings Inc. will post 1.36 earnings per share for the current year.

Bowhead Specialty Company Profile

(Free Report)

Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.

Featured Stories

Institutional Ownership by Quarter for Bowhead Specialty (NYSE:BOW)

Should You Invest $1,000 in Bowhead Specialty Right Now?

Before you consider Bowhead Specialty, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bowhead Specialty wasn't on the list.

While Bowhead Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

2 Chip Stocks Are Soaring—But One Could Break Out This Summer
Congress Bought This Stock at the Bottom—Will You Miss It?
These 3 Penny Stocks Could Surprise Everyone This Summer!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines